New scan seeks to outperform old methods in tracking deadly prostate cancer
NCT ID NCT04158245
Summary
This small pilot study tested whether a newer type of PET scan (using a tracer called 18F-fluciclovine) could better track how well treatments are working for men with advanced, hard-to-treat prostate cancer that has spread. Researchers compared the new scan results to standard CT scans, bone scans, and PSA blood tests to see if it gave a clearer picture of the cancer's response to treatment. The goal was to gather information to improve how doctors monitor this serious disease.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC CASTRATION-RESISTANT PROSTATE CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Tulane Cancer Center Clinic
New Orleans, Louisiana, 70112, United States
Conditions
Explore the condition pages connected to this study.